NIH awards seven new vaccine adjuvant discovery contracts
NIAID has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability. Total funding for these contracts could reach $70 million over five years. September 30, 2014